StayCurrentMD · Glycopyrrolate for Anastomtic Dehiscence in Esophageal Atresia
Follow
Video2 min·Published May 2017Older

Glycopyrrolate for Anastomtic Dehiscence in Esophageal Atresia

With Dr. Abdul Raoof Lamoshi · hosted by Dr. Todd Ponsky

Chapter 1 of 3 · Evidence & Research

Study design

Study Design and Patient Population

Try
Intelligent Search· scoped to esophageal atresia · not medical adviceSearch the whole library →
What the experts said3 expert statements · 8 host summaries
The study was a randomized controlled trial with a very good sample size.
OpinionAbdul Raoof Lamoshi
The results were both statistically and clinically significant.
OpinionAbdul Raoof Lamoshi
Glycopyrrolate is a novel treatment that can have substantial effect on anastomotic leak after esophageal atresia repair, a very complicated problem.
OpinionTodd Ponsky
The study was a prospective randomized control trial studying the effect of glycopyrolate on patients that had leak after esophageal atresia repair.
Host summaryTodd Ponsky summarizes what Dr. Abdul Raoof Lamoshi said · not cited in answers
There were 297 patients over a 10 year period that underwent esophageal atresia repair.
Host summaryTodd Ponsky summarizes what Dr. Abdul Raoof Lamoshi said · not cited in answers
Of the 297 patients, there were 42 leaks, approximately 14%.
Host summaryTodd Ponsky summarizes what Dr. Abdul Raoof Lamoshi said · not cited in answers
The 42 patients with leaks were prospectively randomized into two groups of 21 each, one receiving glycopyrrolate and the other receiving placebo (saline).
Host summaryTodd Ponsky summarizes what Dr. Abdul Raoof Lamoshi said · not cited in answers
The observer was blinded to which treatment group the patient was in.
Host summaryTodd Ponsky summarizes what Dr. Abdul Raoof Lamoshi said · not cited in answers
Chest tube output was 124 mL in the glycopyrrolate treatment group compared to 370 mL in the placebo group.
Host summaryAbdul Raoof Lamoshi summarizing a resource · not cited in answers
Leak resolution was accomplished in 76% of the glycopyrrolate treatment group compared to 29% of the placebo group.
Host summaryAbdul Raoof Lamoshi summarizing a resource · not cited in answers
Oral feeding was achieved in 71% of the glycopyrrolate treatment group compared to only 14% of the placebo group.
Host summaryAbdul Raoof Lamoshi summarizing a resource · not cited in answers